Regeneron PharmaceuticalsREGN 
$1,162.002.04%24h
2.04%24h
Global rank111
Market cap$124.48B
Change 7d-0.00%
YTD Performance32.97%
SP500 benchmarkOutperform
P/E0
P/S9.49
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals (REGN) Total Liabilities
REGN Total Liabilities in 2022: $7.11B
According to Regeneron Pharmaceuticals latest financial reports the total liabilities of REGN is $7.11B, an increase of 8.50% to 2022. At the end of 2022 company had $6.55B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Regeneron Pharmaceuticals is responsible for during its operational activities.
Regeneron Pharmaceuticals (REGN) Total Liabilities History from 2023 to 2022
-
Value:-
REGN Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $7.11B | 8.50% |
| 2022 | $6.55B | -1.73% |
| 2021 | $6.67B | 8.60% |
| 2020 | $6.14B | 65.20% |
| 2019 | $3.72B | 113.42% |
| 2018 | $1.74B | - |
View the Top Total Liabilies Stocks
